视频

The role and structure of the multidisciplinary team in the management of advanced Parkinson’s disease with a focus on the use of levodopa–carbidopa intestinal gel

 

Authors Pedersen SW, Suedmeyer M, Liu LWC, Domagk D, Forbes A, Bergmann L, Onuk K, Yegin A, van Laar T

Received 25 April 2016

Accepted for publication 18 August 2016

Published 4 January 2017 Volume 2017:10 Pages 13—27

DOI https://doi.org/10.2147/JMDH.S111369

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Devang Sanghavi

Peer reviewer comments 4

Editor who approved publication: Professor Scott Fraser

Abstract: A multidisciplinary team (MDT) approach is increasingly recommended in Parkinson’s disease (PD) treatment guidelines, but no standard of care exists for such an approach, and the guidelines do not provide clarification on how it should be implemented. This paper reviews evidence of MDT interventions in people with PD and provides expert clinical perspectives for an MDT approach, with a focus on advanced PD and levodopa–carbidopa intestinal gel (carbidopa–levodopa enteral suspension in the USA). The key recommendations are to enable the best possible treatment of people with PD locally by facilitating a close structured collaboration of different health care professionals working in a fixed network structure; to refer people with PD to established MDT centers in a timely manner; to establish regular meetings for the MDT enabling interdisciplinary exchange and learning; to optimize individual treatment and carefully evaluate available treatment options; to ensure treatment decisions are agreed jointly between people with PD, their caregivers, family, and health care professional; and to include specialists outside of neurology from adjuvant medical departments as necessary when implementing advanced therapies.
Keywords: Parkinson’s disease, multidisciplinary team, advanced therapy, levodopa–carbidopa intestinal gel, carbidopa–levodopa enteral suspension

 

摘要视频链接MDT management for advanced PD